Lipodystrophy: all 165 studies
Page 2 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Compassionate Use of Metreleptin in Previously Treated People With Generalized LipodystrophyActive, not recruitingNCT02262832Phase 3
- Compassionate Use of Metreleptin in Previously Treated People With Partial LipodystrophyActive, not recruitingNCT02262806Phase 2
- Factors Mediating Gut Microbiota Dysbiosis and Metabolic Disease in HIV Patients.CompletedNCT02258685
- Identification of a New Gene Involved in Hereditary LipodystrophyCompletedNCT02056912Not applicable
- Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic AcidStatus unknownNCT02034786Phase 1
- Artefill for the Treatment of HIV-associated Facial LipoatrophyCompletedNCT02009462Phase 1
- Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem CellsCompletedNCT01828723Phase 1
- Egrifta Replacement and Sleep Disordered BreathingWithdrawnNCT01788462
- Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and ObesityCompletedNCT01784289
- Compassionate Use Protocol for the Treatment of Autoinflammatory SyndromesApproved for marketingNCT01724580
- Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment OutcomeCompletedNCT01359917
- Effects of IGF-I in HIV Metabolic DiseaseTerminatedNCT01329744Phase 1
- White Light Scanning to Aid Body Contouring: A Pilot ProjectStatus unknownNCT01093950
- Polyacrylamide Hydrogel Injection in HIV-related LipoatrophyCompletedNCT01077765Phase 3
- Clinical Trial to Assess the Effect of the Change of Efavirenz (EFV) for Lopinavir/Ritonavir (LPV/r) in Lipoatrophy in HIV-infected PatientsCompletedNCT00978237Phase 4
- Exercise for Patients With HIV InfectionsStatus unknownNCT00910936Phase 2/3
- Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With LipoatrophyCompletedNCT00865007Phase 4
- Corticosteroid-induced Lipodystrophy and AdipokinesCompletedNCT00822042
- Autologous Adipose-Derived Stem Cell Transplantation in Patients With LipodystrophyStatus unknownNCT00715546Phase 1
- Expanded Access for Metreleptin for the Treatment of Diabetes Mellitus and/or Hypertriglyceridemia Associated With LipodystrophyNo longer availableNCT00677313
- Follow-up on the HIGH: Low Study - the Longterm Effects of Growth HormoneStatus unknownNCT00662181
- Study to Evaluate Changes in Limb Fat When Switching From a Thymidine AnalogueCompletedNCT00647946Phase 2
- Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With LipodystrophyCompletedNCT00646984Phase 4
- Yoga for the Management of HIV-Metabolic SyndromesCompletedNCT00627380Phase 4
- Novel Therapies for Metabolic Complications of LipodystrophiesCompletedNCT00457938Not applicable
- SHARE: Simple HAART With Abacavir, Reyataz, and EpivirStatus unknownNCT00426296Phase 4
- Safety and Efficacy of Intradermal Injections of Newfill Versus Eutrophill in the Treatment of Facial Lipoatrophy in HIV-infected Patients ANRS 132 SMILECompletedNCT00383734Phase 3
- Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)CompletedNCT00360932
- Clinical Trial to Determine the Efficacy of Sculptra™ Dermal Filler for the Correction of Contour Deformities Caused by LipoatrophyWithdrawnNCT00360139Phase 4
- Safety, Efficacy and Psychological Effects of Treating Antiretroviral Drug-Induced Facial Lipoatrophy With Bio-AlcamidCompletedNCT00333684Phase 2
- Observational Study of Changes in Fat Distribution and Blood Metabolites in HIV Infected AdultsStatus unknownNCT00331448
- Study Comparing Reducing the Dose of Stavudine Versus Switching to Tenofovir in HIV-Infected Patients Receiving Antiretroviral TherapyCompletedNCT00312832Not applicable
- Pravastatin for Hyperlipidaemia in HIV.CompletedNCT00227500Phase 4
- SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial FunctionCompletedNCT00225082
- The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDSCompletedNCT00202241Not applicable
- Lactate Metabolism Study in HIV Infected PersonsCompletedNCT00202228Phase 4
- HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)CompletedNCT00192660Phase 4
- Seronegatives and Metabolic Abnormalities Protocol 2 (SAMA002): Study to Compare the Effect of Kaletra and Combivir® in HIV-Negative Healthy SubjectsCompletedNCT00192621Phase 4
- Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected SubjectsStatus unknownNCT00172315
- Role of the Autonomic Nervous System in HIV-LipodystrophyCompletedNCT00149097
- Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsTerminatedNCT00148850Phase 3
- Switching From Zidovudine to an NNRTI or Lopinavir/Ritonavir in Patients Treated With Zidovudine/ Lamivudine/Abacavir.CompletedNCT00139178Phase 4
- Comparing a Nucleoside-Analogue-Sparing Regimen and a Protease-Inhibitor-Sparing Regimen in HIV Infected PatientsStatus unknownNCT00135460Phase 4
- Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial LipoatrophyTerminatedNCT00126308Phase 4
- TH9507 in Patients With HIV-Associated LipodystrophyCompletedNCT00123253Phase 3
- Evaluation of the Occurrence of Lipoatrophy in HIV-1 Infected Naive PatientsTerminatedNCT00122668Phase 4
- Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With LipoatrophyTerminatedNCT00122655Phase 4
- MEDICLAS Study (Metabolic Effects of Different Classes of AntiretroviralS)Status unknownNCT00122226Phase 4
- The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected PatientsCompletedNCT00119769Phase 4
- A Study of Physical and Metabolic Abnormalities in HIV Infected and Uninfected Children and YouthCompletedNCT00069004
- Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV PatientsCompletedNCT00028314Not applicable
- Changing to Nonprotease Inhibitor Treatment to Improve Side EffectsCompletedNCT00021463Phase 2
- The Effect of Efavirenz and Nelfinavir on the Blood Levels of Certain Lipid-Lowering DrugsCompletedNCT00017758Phase 1
- Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat AbnormalitiesCompletedNCT00015691Not applicable
- Safety and Effectiveness of Fenofibrate and Pravastatin in HIV-Positive Patients With Abnormal Blood LipidsCompletedNCT00006412Phase 3
- Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV DrugsCompletedNCT00006290
- A Study to Determine How and Why HIV-Infected Subjects on Anti-viral Treatment Develop LipodystrophyCompletedNCT00006190Phase 4
- Underlying Abnormalities in Fat and Muscle Leading to Lipodystrophy SyndromeCompletedNCT00006185Phase 1
- The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected ChildrenCompletedNCT00006064
- Leptin to Treat LipodystrophyCompletedNCT00005905Phase 2
- A Study of Increased Lactic Acid and Abnormal Fat Distribution in HIV-Positive PatientsCompletedNCT00005764Phase 4
- Study of Alpha-2 Adrenergic Receptor Dysfunction in Regional LipoatrophyCompletedNCT00004329
- A Study of Amprenavir in Patients With Protease Inhibitor-Related ComplicationsCompletedNCT00002417Not applicable
- Comparing Magnetic Resonance Imaging/Spectroscopy TechniquesTerminatedNCT00001219
- Metabolism and Body Shape of Healthy Children and Children With Chronic InfectionsCompletedNCT00001142